PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links


Article published in Urologia Polska 2000/53/2.

authors

Bronisław A. Zachara, Karolina Szewczyk
Katedra i Zakład Biochemii AM w Bydgoszczy
Kierownik: prof. dr hab. med. B. A. Zachara

keywords

prostate prostatic carcinoma nutrients

references

  1. [1] Armstrong, B., Doll, R.: Environmental factors and cancer incidence and mor-
  2. tal-ity in different countries, with special reference to dietary practices. Int. J. Can-
  3. cer 1975,15, 617-631.
  4. [2] Borówka, A.: Epidemiology of the prostate carcinoma in Poland. Urol. Pol. 1999,
  5. 52, supl. 3A, 1-6.
  6. [3] Boyle, R, Severi, G.: Epidemiology of prostate cancer chemoprevention. Eur.
  7. Urol. 1999, 35, 370-376.
  8. [4] Clark, L. C: Recent developments in the prevention of human cancer with seleni-
  9. um. Sel.-Tel. Develop. Assoc. Nov. 1997,1-3.
  10. [5] Clark, L. C, Combs, G. F. Jr, Turnbull, B. W., Slate, E. H., Chalker, D.
  11. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G.
  12. Krongrad, A., Lesher, J. L., Park, H. K., Sanders, B. B. Jr, Smith, C. L.,
  13. Taylor, J. R.: Effects of selenium supplementation for cancer prevention in pa-
  14. tients with carcinoma of the skin: A randomized controlled trial. JAMA 1996, 276,
  15. 1957-1963.
  16. [6] Clark, L. C, Dalkin, B., Krongrad, A., Combs, G. F. Jr, Turnbull, B.
  17. W., Slate, E. H., Witherington, R., Herlong, J. H., Janosko, E., Car-
  18. penter, D., Borosso, C, Falk, S., Rounder, J.: Decreased incidence of pros-
  19. tate cancer with selenium supplementation: results of a double-blind cancer preven-
  20. tion trial Br. J. Urol. 1998, 81, 730-734.
  21. [7] Clinton, S. K.: Lycopene: Chemistry, biology, and implications for human health
  22. and disease. Nutr. Rev. 1998, 56, 35-51.
  23. [8] Clinton, S. K., Giovannucci, E.: Diet, nutrition, and prostate cancer. Ann.
  24. Rev. Nutr. 1998,18, 413-420.
  25. [9] Combs, G. F. Jr: Selenium and cancer prevention. In: antioxidants and disease
  26. prevention; H. S. Garewal (red), CRC Press, Boca Raton, New York, 1997, 97-
  27. 113.
  28. [10] Combs, G. F. Jr, Clark L. C, Turnbull, B. W.: Reduction of cancer risk with
  29. an oral supplement of selenium. Biomed. Environ. Sci. 1997,10, 227-234.
  30. [11] Combs, G. F., Jr, Gray, W. P.: Chemopreventive agents: selenium. Pharmacol.
  31. Ther. 1998, 79,179-192.
  32. [12] Comstock, G. W., Bush, T. L., Helzlsouer, K.: Serum retinol, beta-carotene,
  33. vitamin E, and selenium as related to subsequent cancer of specific sites. Am. J.
  34. Epidemiol. 1992,135,115-121.
  35. [13] DiMascio, P., Kaiser, S., Sies, H.: Lycopene as the most efficient biological
  36. carotenoid singlet oxygen ąuencher. Arch. Biochem. Biophys. 1989, 274,1-7.
  37. [14] Ekman, R: Genetic and environmental factors in prostate cancer genesis: Identi-
  38. fying high-risk cohorts. Eur. Urol. 1999, 35, 362-369.
  39. [15] Fradet, Y, Meyer, R, Bairati, I., Shadmani, R., Moore, L.: Dietary fat
  40. and prostate cancer progression and survival. Eur. Urol. 1999, 35, 388-391.
  41. [16] Giovannucci, E.: Tomatoes, tomato-based products, lycopene, and cancer: a re-
  42. view of the epidemiologic literature. J. Nat. Cancer Inst. 1999, 91, 317-331.
  43. [17] Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J.,
  44. Ascherio, A., Chute, C. C, Willett, W. C: A prospective study of dietary fat
  45. and risk of prostate cancer. J. Nat. Cancer Inst. 1993, 85.
  46. [18] Hardell, L., Degerman, A., Tomic, R., Marklund, S. L., Bergfors, M.:
  47. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients
  48. with prostate cancer or benign hyperplasia. Eur. J. Cancer Prev. 1995, 4, 91-95.
  49. [19] Hartman, T. )., Albanes, D., Pietinen, P., Hartman, A. M., Rautalahti,
  50. M., Tangrea, J. A., Taylor, P. R.: The association between baseline vitamin E,
  51. selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer preven-
  52. tion study. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 335-340.
  53. [20] Hebert, J. R., Hurley, T. G., Olendzki, B. C, Teas, J., Ma, Y., Hampl, J.
  54. S.: Nutritional and socioeconomic factors in relation to prostate cancer mortality:
  55. a cross-national study. J. Nat. Cancer Inst. 1998, 90,1637-1647.
  56. [21] Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J.
  57. K., Hartman, A. M., Haapakoski, J., Malila, N., Rautalahti, M.,
  58. Ripatti, S., Maenpaa, H., Teerenhovi, L., Koss, L., Virolainen, M.,
  59. Edwards, B. K.: Prostate cancer and supplementation with ?-tocopherol and beta-
  60. carotene: Incidence and mortality in a controlled trial. J. Natl Cancer Inst. 1998,
  61. 90, 440-446.
  62. [22] Heinonen, O. P., Huttunen, J. K., et al.: The effect of vitamin E and beta-
  63. carotene on the incidence of lung cancer and other cancers in male smokers. New.
  64. Engl. J. Med. 1994, 330, 1029-1035.
  65. [23] Jung, K., Seidel, B., Rudolph, B., Lein, M., Cronauer, M. V., Henke,
  66. W., Hampel, G., Schnorr, D., Loening, S. A.: Antioxidant enzymes in ma-
  67. lignant prostate cells and in primary cultured prostatic cells. Free Rad. Biol. Med.
  68. 1997, 23,127-133.
  69. [24] Kelloff, G. J., Lieberman, R., Steele, V. E., Boone, C. W., Lubet, R. A.,
  70. Kopelovitch, L., Malone, W. A., Crowell, J. A., Sigman, C. C: Chemo-
  71. prevention of prostate cancer: Concepts and strategies. Eur. Urol. 1999, 35, 342-
  72. 350.
  73. [25] Knekt, P., Aroma, A., Maatela, J., Alfthan, G., Aaran, R.-K., Hakama,
  74. M., Hakulinen, T., Peto, R., Teppo, L.: Serum selenium and subsequent risk
  75. of cancer among Finnish men and women. J. Nat. Cancer Inst. 1990, 82, 864-868.
  76. [26] Kolonel, L. N., Nomura, A. M. Y, Cooney, R. V.: Dietary fat and prostate
  77. cancer: current status. J. Nat. Cancer Inst. 1999, 91, 414-428.
  78. [27] Mettlin, C, Selenskas, S., Natarajan, N., Huben, R.: Beta-carotene and
  79. animal fats and their relationship to prostate cancer risk. Cancer 1989, 64, 605-612.
  80. [28] Mills, P. K., Beeson, W. L., Phillips, R. L., Fraser, G. E.: Cohort study of
  81. diet, lifestyle, and prostate cancer in adventist men. Cancer 1989, 64, 598-604.
  82. [29] Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J. R., Visek, W. J.,
  83. Clinton, S. K.: Energy intake and prostate tumor growth, angiogenesis, and vascu-
  84. lar endothelial growth factor expression. J. Nat. Cancer Inst. 1999, 91, 512-523.
  85. [30] Pawłowicz, Z., Zachara, B. A.,Trafikowska, U., Maciąg, A., Marchaluk,
  86. E., Nowicki, A.: Blood selenium concentrations and glutathione peroxidase ac-
  87. tivities in patients with breast cancer and with advanced gastrointestinal cancer. J.
  88. Trace Elem. Electrol. Health Dis. 1991, 5, 275-277.
  89. [31] Schrauzer, G. N., White, D. A., Schneider, C. J.: Cancer mortality correla-
  90. tion studies. III. Statistical association with dietary selenium intakes. Bioinorg.
  91. Chem. 1977, 7, 23-24.
  92. [32] Thomas, J. A.: Diet, micronutrients, and the prostate gland. Nutr. Rev. 1999, 57,
  93. 95-103.
  94. [33] Torun, M., Aldemir, H., Yardim, S.: Serum selenium levels in various cancer
  95. types. Trace Elem. Electrol. 1995,12,186-190.
  96. [34] Webber, M. M., Perez-Ripoll, E. A., James, G. T.: Inhibitory effects of sele-
  97. nium on the growth of DU-145 human prostate carcinoma cells in vitro. Biochem.
  98. Biophys. Res. Commun. 1985, 130, 603-609.
  99. [35] Willett, W. C, Hunter, D. J.: Vitamin A and cancers of the breast, large bowel,
  100. and prostate: Epidemiologic evidence. Nutr. Rev. 1994, 52, 553.
  101. [36] Willett, W. C, Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S.,
  102. Rosner, B., Taylor, J. O., Schneider, K.: Prediagnostic serum selenium and
  103. risk of cancer. Lancet 1983,130-134.
  104. [37] Yoshizawa, K., Willett, W. C, Morris, S. J., Stampfer, M. J.,
  105. Spiegelman, D., Rimm, E. B., Giovannucci, E.: Study of prediagnostic sele-
  106. nium level in toenails and the risk of advanced prostate cancer. J. Nat. Cancer Inst.
  107. 1998, 90,1219-1224.
  108. [38] Zachara, B. A.: Mammalian selenoproteins. J. Trace Elem. Electrol. Health Dis.
  109. 1992, 6,137-151.
  110. [39] Zachara, B. A., Marchaluk-Wisniewska, E., Maciąg, A., Peplihski, J.,
  111. Skokowski,-J.; Lambrecht, W.: Decreased selenium concentration and glu-
  112. tathione peroxidase activity in blood and increase of these parameters in malignant
  113. tissue of lung cancer patients. Lung 1997, 175, 321-332.
  114. [40] Zaichick, V. Y., Sviridova, T. V., Zaichick, S. V.: Zinc concentration in
  115. human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int. J. Urol.
  116. Nephrol. 1996, 28, 687-694.
  117. [41] Zaichick, V. Y, Sviridova, T. V., Zaichick, S. V.: Zinc in the human pros-
  118. tate gland: normal, hyperplastic, and cancerous. Int. J. Urol. Nephrol. 1997, 29,
  119. 565-574.
  120. [42] Zaichick, V. Y., Zaichick, S. V.: Role of zinc in prostate cancer agenesis. In:
  121. Mengen- und Spurenelemente. M. Anke et al. (red.), 19. Arbeitstagung 1999,
  122. Verlag Harald Schubert, 1. Auflage, Leipzig 1999, 104-115.